Upper respiratory tract disease treatment market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infection commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, otitis media, and the common cold. This can be treated using various drugs, targeting disease-causing pathogens like bacteria and viruses. Increasing number of Adults with asthma, congestive heart failure, and COPD are at higher risk of suffering from respiratory syncytial virus infection lead to the growth of the market. According to a study of plos computing biology US, URTD caused by a variety of bacteria and viruses, and the infection can vary from a mild colds to life-threatening pneumonia. Being one of the most common diseases, the global burden of URTI in 2019 is estimated to be 17.2 billion. Although a majority of individuals contracting URTIs present mild symptoms, the estimated economic burden of non-influenza related viral URTIs in the United States alone is estimated to be 22.5 billion USD and an estimated 2 billion USD is spent on over-the-counter treatments for URTIs.
Get Free Sample link @ https://www.omrglobal.com/request-sample/upper-respiratory-tract-disease-treatment-market
The global upper respiratory tract disease treatment market is segmented on the category, treatment, and drug class. Based on the category, the market is sub-segmented into OTC and Prescription. Based on the treatment, the market is sub-segmented into topical treatment, cough suppressant, nasal decongestant and other. Further, on the basis of drug class, the market is sub-segmented into NSAID, antibiotics and others. Among the category, the OTC sub-segment is anticipated to hold a considerable share of the market owing to its easy availability without any prescription and it is effective in treating
full report of Upper Respiratory Tract Disease Treatment Market available @ https://www.omrglobal.com/industry-reports/upper-respiratory-tract-disease-treatment-market
Market Coverage
Market number available for – 2023-2029
Base year- 2022
Forecast period- 2023-2029
Segment Covered- By Source, By Product Type, By Applications
Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
Inc., and others
Market Segmentation
Global Upper respiratory tract disease Treatment Market by Category
- OTC
- Prescription
Global Upper respiratory tract disease Treatment Market by Treatment
- Topical treatment
- Cough Suppressant
- Nasal Decongestant
- Others (Antihistamines, Guaifenesin, and Cromolyn)
Global Upper respiratory tract disease Treatment Market by Drug class
- NSAID
- Antibiotics
- Others (Ibuprofen)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Alcon, Inc.
- AstraZeneca Plc
- Cipla Limited
- CSL Ltd.
- Reddy’s Laboratories Ltd.
- Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Lupin Limited
- Market positioning of vendors
- Merck & Co., Inc.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Sandoz, Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global upper respiratory tract disease treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/upper-respiratory-tract-disease-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
